HAILEY 24 FE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hailey 24 Fe, and when can generic versions of Hailey 24 Fe launch?
Hailey 24 Fe is a drug marketed by Glenmark Pharms Ltd and is included in one NDA.
The generic ingredient in HAILEY 24 FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for HAILEY 24 FE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HAILEY 24 FE at DailyMed |
Recent Clinical Trials for HAILEY 24 FE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Toulouse | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for HAILEY 24 FE
US Patents and Regulatory Information for HAILEY 24 FE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharms Ltd | HAILEY 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 204847-001 | Nov 17, 2017 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |